Complement dysfunction in hemolytic uremic syndrome

Current Opinion in Rheumatology

Volumn 18, Issue 5, 2006, Pages 548-555

  Zipfel, Peter F ^a,b   Skerka, Christine ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Autoantibodies; Complement dysfunction; Factor H; Factor I; Membrane cofactor protein

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3BBB; COMPLEMENT FACTOR H; FIBRINOGEN; GENE PRODUCT; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG;

CLINICAL FEATURE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DISORDER; DISEASE ASSOCIATION; ENZYME ACTIVITY; FACTOR H GENE; FACTOR I GENE; GENE; GENE MUTATION; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; MCP GENE; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN FUNCTION; RECURRENT DISEASE; REVIEW; SYMPTOM;

ADULT; AUTOANTIBODIES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY DISEASES; MUTATION; PLASMAPHERESIS; PLATELET COUNT; PROGNOSIS;

EID: 33746926773     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000240370.47336.ae     Document Type: Review

References (42)

1. Zipfel PF, editor. Complement and kidney diseases. Basel: Birkhäuser; 2006. This book covers and combines several in-depth aspects of defective complement in kidney disease, particularly in MPGN and HUS.
2. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:1035-1050. A recent and actual review which covers the broad aspects of complement regulation in various diseases.
3. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 2006; 176:1305-1310. A recent and timely review which demonstrates the role of complement regulation in various clinical settings and its association with a broad range of diseases.
4. Atkinson JP, Liszewski MK, Richards A, et al. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue. Ann N Y Acad Sci 2005; 1056:144-152. A recent reviewwhich analyses the role of insufficient complement regulation in HUS.
5. Siegler R, Oakes R. Hemolytic uremic syndrome: pathogenesis, treatment, and outcome. Curr Opin Pediatr 2005; 17:200-204.
6. Zipfel PF, Heinen S, Jozsi M, Skerka C. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43:97-106. This review summarizes how mutations in genes coding for complement regulators cause kidney diseases and relate to age-related macular degeneration.
7. Thurnberg D, Cook TH. Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens 2005; 14:223-228.
8. Zipfel PF, Misselwitz J, Licht C, Skerka C. The role of defective complement control in haemolytic uraemic syndrome. Semin Thromb Hemost 2006; 32:146-154.
9. Warwicker P, Goodship TH, Donne RL. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998; 53:836-844.
10. Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 2001; 68:478-484.
11. Caprioli J, Bettinaglio P, Zipfel PF, et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001; 12:297-307.
12. Neumann HP, Salzmann M, Bohnert-Iwan B, et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 2003; 40:676-681.
13. Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 2003; 100:12966-12971.
14. Noris M, Brioschi S, Caprioli J, et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003; 362:1542-1547.
15. Esparza-Gordillo J, Goicoechea de Jorge E, et al. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in large, multiple affected pedigree. Mol Immunol 2006; 43:1769-1775.
16. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004; 41:e84.
17. Kavanagh D, Kemp EJ, Mayland E, et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:2150-2155. Extends the recent findings of Femaux Bacchi et al. and identifies the frequency of factor I gene mutations in HUS.
18. Vaziri-Sani F, Holmberg L, Sjoholm AG, et al. Phenotypic expression of factor H mutations inpatients with atypical haemolytic uremic syndrome. Kidney Int 2006; 69:981-988.
19. Nordahl EA, Rydengard V, Nyberg P, et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci USA 2004; 101:16879-16884.
20. Zipfel PF. Complement factor H: physiology and pathophysiology. Semin Thromb Hemost 2001; 27:191-199.
21. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004; 41:355-367.
22. Manuelian T, Hellwage J, Meri S, et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 2003; 111:1181-1190.
23. Jokiranta TS, Cheng ZZ, Seeberger H, et al. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am J Pathol 2005; 167:1173-1181. This manuscript shows that the C-terminus of factor H mediates recognition functions and binding to endothelial cells.
24. Skerka C, Józsi M. Role of complement and factor H in haemolytic uraemic syndrome. In: Zipfel PF, editor. Complement and kidney diseases. Basel: Birkhäuser; 2006. pp. 85-109.
25. Saunders RE, Goodship TH, Zipfel PF, Perkins SJ. An interactive web database of factor H associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 2006; 27:21-30. This group in London has generated an interactive web database which summarizes all reported factor H gene mutations and the structural consequences of the individual mutations. It is of interest to the community to keep the database active in order to use it as a valuable resource for mutation analysis.
26. Jozsi M, Heinen S, Hartmann A, et al. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions. J Am Soc Nephrol 2006; 17:170-177. The authors show that all seven analyzed HUS-associated mutations of factor H located in the C-terminal domains 19 and 20 affect recognition functions.
27. Liszewski MK, Farries TC, Lublin DM, et al. Control of the complement system. Adv Immunol 1996; 61:201-283.
28. Morley BJ. Factor I. In: Morley BJ, Walport MJ, editors. The complement factor book. Facts Book Series. London: Academic Press; 2000.
29. Kavanagh D, Kemp EJ, Richards A, et al. Does complement factor B have a role in the pathogenesis of atypical HUS? Mol Immunol 2006; 43:856-859. This study excludes the complement regulator factor B from the list of HUS candidate genes.
30. Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 2005; 14:703-712.
31. Fremeaux-Bacchi V, Kemp EJ,Goodship JA, et al. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 2005; 42:852-856.
32. Caprioli J, Castelletti F, Bucchioni S, et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003; 12:3385-3395.
33. Heinen S, Sanchez-Corral P, Jackson MS, et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Genetics 2006; 27:292-293.
34. Hegasy GA, Manuelian T, Hogasen K, et al. The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. Am J Pathol 2002; 161:2027-2034.
35. Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:555-563. The authors show a new aspect for the mechanisms of HUS. It is the first demonstration of autoantibodies in HUS and identifies a novel mechanism.
36. Licht C, Hoppe B. Complement defects in children which result in kidney diseases: diagnosis and therapy. In: Zipfel PF, editor. Complement and kidney diseases. Basel: Birkhäuser; 2006. pp. 85-109.
37. Filler G, Radhakrishnan S, Strain L, et al. Challenges in the management of infantile factor H associated hemolytic uremic syndrome. Pediatr Nephrol 2004; 19:908-911.
38. Licht C, Weyersberg A, Heinen S, et al. Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. Am J Kidney Dis 2005; 45:415-421.
39. Licht C, Heinen S, Jozsi M, et al. Deletion of Lys224 in regulatory domain 4 of factor H reveals a novel pathomechanism for dense deposit disease (MPGNII). Kidney Int 2006; 12 April [Epub ahead of print].
40. Kavanagh D, Goodship TH. Membrane cofactor protein and factor I: mutations and transplantation. Semin Thromb Hemost 2006; 32:155-159.
41. Remuzzi G, Ruggenenti P, Colledan M, et al. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am J Transplant 2005; 5:1146-1150.
42. Cheong HI, Lee BS, Kang HG, et al. Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 2004; 19:454-458.